3-hydroxykynurenine has been researched along with Chronic Disease in 3 studies
3-hydroxykynurenine: RN given refers to cpd without isomeric designation
3-hydroxykynurenine : A hydroxykynurenine that is kynurenine substituted by a hydroxy group at position 3.
hydroxykynurenine : A hydroxy-amino acid that is kynurenine substituted by a single hydroxy group at unspecified position. A "closed" class.
Chronic Disease: Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pawlak, K | 1 |
| Tankiewicz, J | 1 |
| Mysliwiec, M | 1 |
| Pawlak, D | 1 |
| Laugeray, A | 1 |
| Launay, JM | 1 |
| Callebert, J | 1 |
| Surget, A | 1 |
| Belzung, C | 1 |
| Barone, PR | 1 |
| Knubel, CP | 1 |
| Martínez, FF | 1 |
| Acosta Rodríguez, EV | 1 |
| Altamirano, A | 1 |
| Rivarola, HW | 1 |
| Diaz Luján, C | 1 |
| Fretes, RE | 1 |
| Cervi, L | 1 |
| Motrán, CC | 1 |
3 other studies available for 3-hydroxykynurenine and Chronic Disease
| Article | Year |
|---|---|
Tissue factor/its pathway inhibitor system and kynurenines in chronic kidney disease patients on conservative treatment.
Topics: Adult; Aged; Case-Control Studies; Chronic Disease; Female; Humans; Kidney Diseases; Kynurenine; Lip | 2009 |
Peripheral and cerebral metabolic abnormalities of the tryptophan-kynurenine pathway in a murine model of major depression.
Topics: Animals; Brain; Chronic Disease; Depressive Disorder, Major; Disease Models, Animal; Hydroxyindoleac | 2010 |
3-Hydroxy kynurenine treatment controls T. cruzi replication and the inflammatory pathology preventing the clinical symptoms of chronic Chagas disease.
Topics: Animals; Chagas Disease; Chronic Disease; Female; Inflammation; Interferon-gamma; Kynurenine; Mice; | 2011 |